Opus Genetics, Inc. (IRD) insider trading.
In Q3 2026, insiders at Opus Genetics, Inc. reported 8 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $214K.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 5
- Net shares, P minus S
- -57,331
- Insiders
- 5
- Last filed
- 2026-09-11
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Magrath George | Director, Officer · Chief Executive Officer | 3 | 0 | 1 |
| Gagnon Robert E. | Officer · Chief Financial Officer | 2 | 0 | 2 |
| Gallagher Cam | Director | 1 | 0 | 0 |
| Schachle Joseph K | Officer · Chief Operating Officer | 1 | 0 | 1 |
| Yerxa Benjamin R | Director, Officer · President | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-09 | Magrath George | M (A) | 392,157 | $1.15 | 2,124,026 | Form 4 |
| 2026-09-09 | Magrath George | F (D) | 75,541 | $5.97 | 2,048,485 | Form 4 |
| 2026-09-08 | Gallagher Cam | M (A) | 784,314 | $1.15 | 2,800,111 | Form 4 |
| 2026-09-03 | Gagnon Robert E. | S (D) | 28,000 | $4.54 | 556,375 | Form 4 |
| 2026-07-23 | Gagnon Robert E. | S (D) | 7,783 | $2.95 | 584,375 | Form 4 |
| 2026-07-23 | Magrath George | S (D) | 9,475 | $2.95 | 1,731,869 | Form 4 |
| 2026-07-23 | Schachle Joseph K | S (D) | 4,644 | $2.94 | 291,440 | Form 4 |
| 2026-07-23 | Yerxa Benjamin R | S (D) | 7,429 | $2.97 | 704,106 | Form 4 |
Transaction codes in this quarter
Get IRD insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1228627&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · IRD company page · Opus Genetics, Inc. on SEC.gov
Questions
Are insiders buying or selling Opus Genetics, Inc. (IRD)?
In Q3 2026, insiders at Opus Genetics, Inc. reported 8 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $214K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Opus Genetics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/ird.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.